Publications by the researcher in collaboration with Emilio Bouza Santiago (37)

2020

  1. Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))

    Clinical Microbiology and Infection

  2. Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  3. Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

2019

  1. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 607-614

2018

  1. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

  2. Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 6

  3. Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 3

  4. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

    Medical Mycology, Vol. 56, Núm. 7, pp. 903-906

  5. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect

    Clinical Microbiology and Infection, Vol. 24, Núm. 12, pp. 1343.e1-1343.e4

  6. Is biofilm production a prognostic marker in adults with candidaemia?

    Clinical Microbiology and Infection, Vol. 24, Núm. 9, pp. 1010-1015

2017

  1. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 1969-1976

  2. The etest performed directly on blood culture bottles is a reliable tool for detection of fluconazole-resistant Candida albicans isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

  3. Las placas de agar dextrosado de Sabouraud con fluconazol no son útiles para la detección de resistencia en Candida albicans

    Revista Espanola de Quimioterapia, Vol. 30, Núm. 2, pp. 127-130

  4. In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

  5. Frequency of the paradoxical effect measured using the EUCAST procedure with micafungin, anidulafungin, and caspofungin against Candida species isolates causing candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 1

  6. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

2016

  1. Erratum for Marcos-Zambrano et al., Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin

    Antimicrobial Agents and Chemotherapy

  2. Erratum for Marcos-Zambrano et al., Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center

    Antimicrobial Agents and Chemotherapy

  3. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms

    The Journal of antimicrobial chemotherapy, Vol. 71, Núm. 9, pp. 2498-2501

  4. Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in Echinocandin-Resistant yeast species

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3579-3586